Clinical Trials Browser

Phase 2 × TH 302 × CNS × Clear all

NCT02342379 2020-04-10

TH-302 in Combination With Bevacizumab for Glioblastoma

Phase 2 Completed

35 enrolled 6 charts

Glioblastoma

NCT01403610 2019-07-24

Safety and Efficacy Study of TH-302 CNS Penetration in Recurrent High Grade Astrocytoma Following Bevacizumab

Phase 2 Completed

28 enrolled 9 charts

Glioma